Advertisement
Letter to the editor| Volume 7, ISSUE 4, P506-507, August 1993

Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation

      This paper is only available as a PDF. To read, Please Download here.

      References

        • Kormos R.L.
        • Thompson M.
        • Hardesty R.L.
        • et al.
        Utility of preoperative right heart catheterization data as a predictor of survival after heart transplantation.
        J Heart Transplant. 1986; 5: 391
        • Kirklin J.K.
        • Naften O.C.
        • McGiffin D.C.
        • et al.
        Analysis of morbid events and risk factors for death after cardiac transplantation.
        J Am Coll Cardiol. 1988; 11: 917-924
        • Bourge R.C.
        • Kirklin J.K.
        • Naftel D.C.
        • et al.
        Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
        J Thorac Cardiovasc Surg. 1991; 101: 432-445
        • Pepke Zaba J.
        • Higenbottam T.W.
        • Dinh-Xuan A.T.
        • et al.
        Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
        Lancet. 1991; 338: 1173-1174
        • Frostell C.
        • Fratacci M.D.
        • Wain J.C.
        • et al.
        Inhaled nitric oxide, a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
        Circulation. 1991; 83: 2038-2047
        • Girard C.
        • Lehot J.J.
        • Clerc J.
        • et al.
        Inhaled nitric oxide in pulmonary hypertension following mitral valve replacement.
        Anesthesiology 1991. 1991; 75: A984